scholarly article | Q13442814 |
P356 | DOI | 10.1038/SJ.BJP.0703517 |
P8608 | Fatcat ID | release_ez5bh7vo55enrexgely3dvphte |
P932 | PMC publication ID | 1572284 |
P698 | PubMed publication ID | 10960076 |
P5875 | ResearchGate publication ID | 12362054 |
P2093 | author name string | R J Evans | |
M P Mahaut-Smith | |||
M G Rolf | |||
S J Ennion | |||
P2860 | cites work | Receptors for purines and pyrimidines | Q28283941 |
Selectivity of diadenosine polyphosphates for rat P2X receptor subunits | Q28371849 | ||
High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets | Q28372253 | ||
Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors | Q28505454 | ||
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7) | Q28568856 | ||
A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP | Q28573068 | ||
The human platelet ADP receptor activates Gi2 proteins | Q28637611 | ||
Receptor-activated single channels in intact human platelets | Q28646164 | ||
Role of P2Y1 purinoceptor in ADP-induced platelet activation | Q32099402 | ||
Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change | Q33178933 | ||
Role of intracellular signaling events in ADP-induced platelet aggregation. | Q33179086 | ||
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice | Q33903557 | ||
Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets | Q34252209 | ||
A P2X purinoceptor expressed by a subset of sensory neurons | Q34296113 | ||
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons | Q34296118 | ||
Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor | Q34388137 | ||
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells | Q34416899 | ||
Towards a revised nomenclature for P1 and P2 receptors | Q34424522 | ||
Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets | Q34453608 | ||
Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses | Q34793460 | ||
Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation | Q36166958 | ||
Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets | Q36895115 | ||
P2 receptor subtypes in the cardiovascular system | Q36899623 | ||
Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry | Q37460532 | ||
Overview. Purinergic mechanisms | Q37610882 | ||
Secretable Storage Pools in Platelets | Q38077642 | ||
P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms | Q38148094 | ||
An antagonist-insensitive P2X receptor expressed in epithelia and brain | Q38362921 | ||
Effects of diadenosine polyphosphates (Ap(n)As) and adenosine polyphospho guanosines (Ap(n)Gs) on rat mesenteric artery P2X receptor ion channels | Q38819450 | ||
The inositol 1,4,5-trisphosphate (InsP3) receptor | Q40415550 | ||
Receptors for ADP on human blood platelets. | Q40664358 | ||
Agonist action of adenosine triphosphates at the human P2Y1 receptor | Q40987858 | ||
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). | Q41321556 | ||
Nucleotide receptors | Q41541504 | ||
Purinoceptor-evoked calcium signalling in human platelets | Q41682742 | ||
Abundant amounts of diadenosine 5′,5‴-P1,P4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets | Q41785105 | ||
ADP evokes biphasic Ca2+ influx in fura-2-loaded human platelets. Evidence for Ca2+ entry regulated by the intracellular Ca2+ store | Q41900836 | ||
Resting and ADP-evoked changes in cytosolic free sodium concentration in human platelets loaded with the indicator SBFI. | Q42470086 | ||
ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor | Q42543394 | ||
Rapid ADP-evoked currents in human platelets recorded with the nystatin permeabilized patch technique | Q43554338 | ||
The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets | Q44154794 | ||
ADP-induced rapid inward currents through Ca(2+)-permeable cation channels in mouse, rat and guinea-pig megakaryocytes: a patch-clamp study | Q46896453 | ||
The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. | Q47929427 | ||
The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. | Q54014344 | ||
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. | Q54077482 | ||
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal | Q59065336 | ||
Intracellular Ca2+ activates phospholipase C | Q69073582 | ||
Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man | Q70623270 | ||
Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets | Q71058907 | ||
Three cation influx currents activated by purinergic receptor stimulation in rat megakaryocytes | Q71675871 | ||
Cytoplasmic Ca2+ oscillation in rat megakaryocytes evoked by a novel type of purinoceptor | Q72774621 | ||
P2Y receptors: in the middle of the road | Q73536421 | ||
Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel | Q73774599 | ||
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines | Q74019347 | ||
Depolarization-evoked Ca2+ release in a non-excitable cell, the rat megakaryocyte | Q74525935 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 108-114 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets | |
P478 | volume | 131 |
Q39317743 | 5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor |
Q28484779 | A characterization of scale invariant responses in enzymatic networks |
Q24673329 | A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors |
Q43954485 | ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. |
Q44709204 | ATP binding at human P2X1 receptors. Contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists |
Q33727708 | Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes |
Q35122793 | Activation and regulation of purinergic P2X receptor channels |
Q40586327 | Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel and sensitive approach for their rapid up or downregulation |
Q34322713 | An elusive receptor is finally caught: P2Y(12'), an important drug target in platelets |
Q26799623 | Blood cells: an historical account of the roles of purinergic signalling |
Q38830299 | Calcium Signalling through Ligand-Gated Ion Channels such as P2X1 Receptors in the Platelet and other Non-Excitable Cells. |
Q43528325 | Cardiovascular biology. Small cells, big issues |
Q35952737 | Cellular distribution and functions of P2 receptor subtypes in different systems |
Q37127241 | Chlorin e6 Prevents ADP-Induced Platelet Aggregation by Decreasing PI3K-Akt Phosphorylation and Promoting cAMP Production. |
Q34500354 | Cloning and characterization of a P2X receptor expressed in the central nervous system of Lymnaea stagnalis |
Q40393685 | Clopidogrel: cardiologists' panacea or neurologists' headache? |
Q45140464 | Direct voltage control of signaling via P2Y1 and other Galphaq-coupled receptors |
Q44580742 | Discrete but simultaneous release of adenine nucleotides and serotonin from mouse megakaryocytes as detected with patch- and carbon-fiber electrodes |
Q44120735 | Effects of a P2Y(12) receptor antagonist on the response of equine platelets to ADP. Comparison with human platelets |
Q35809098 | Emerging roles for P2X1 receptors in platelet activation |
Q37435622 | Functional assessment of isolated mitochondria in vitro |
Q42644198 | Fundamental limitation of the instantaneous approximation in fold-change detection models |
Q40555892 | G-protein-coupled receptor regulation of P2X1 receptors does not involve direct channel phosphorylation |
Q38109969 | Harnessing the platelet signaling network to produce an optimal hemostatic response. |
Q38306676 | Historical perspective on ADP-induced platelet activation |
Q28569271 | Identification of an intersubunit cross-link between substituted cysteine residues located in the putative ATP binding site of the P2X1 receptor |
Q34496403 | Identification, characterization, and inhibition of the platelet ADP receptors |
Q44689561 | Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1. |
Q30836211 | Inhibition of ADP-triggered blood platelet aggregation by diadenosine polyphosphate analogues |
Q42167762 | Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease |
Q41304796 | Inhibition of platelet function with clopidogrel, as measured with a novel whole blood impedance aggregometer in horses |
Q30663919 | Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases |
Q46432730 | Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes |
Q44185612 | Interaction between ATP and catecholamines in stimulation of platelet aggregation |
Q42129293 | Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels |
Q28367095 | Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs |
Q39572678 | Novel consequences of voltage-dependence to G-protein-coupled P2Y1 receptors |
Q28267257 | Orthosteric and allosteric binding sites of P2X receptors |
Q37494937 | P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window |
Q88160630 | P2Y12 receptor modulation of ADP-evoked intracellular Ca2+ signalling in THP-1 human monocytic cells |
Q89524343 | Pharmacological and genetic characterisation of the canine P2X4 receptor |
Q28237411 | Pharmacology of P2X channels |
Q44919367 | Plasma and intracellular membrane inositol 1,4,5-trisphosphate receptors mediate the Ca(2+) increase associated with the ATP-induced increase in ciliary beat frequency |
Q83875488 | Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation |
Q42326717 | Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores |
Q36691632 | Platelet P2 receptors: old and new targets for antithrombotic drugs |
Q73308425 | Platelets and P2X1: is ADP really an agonist? |
Q28221012 | Primary and secondary agonists can use P2X(1) receptors as a major pathway to increase intracellular Ca(2+) in the human platelet |
Q30476424 | Properties of the demarcation membrane system in living rat megakaryocytes. |
Q82370190 | Purinergic activation of rat skeletal muscle membranes increases Vmax and Na+ affinity of the Na,K-ATPase and phosphorylates phospholemman and α1 subunits |
Q46864668 | Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6. |
Q41841024 | Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets |
Q38830286 | Regulation of Platelet Function by Orai, STIM and TRP. |
Q34744843 | Schistosome apyrase SmATPDase1, but not SmATPDase2, hydrolyses exogenous ATP and ADP |
Q37675752 | Schistosome tegumental ecto-apyrase (SmATPDase1) degrades exogenous pro-inflammatory and pro-thrombotic nucleotides. |
Q79331068 | Sensitivity limits for voltage control of P2Y receptor-evoked Ca2+ mobilization in the rat megakaryocyte |
Q52690191 | Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets. |
Q37702209 | The P2X1 ion channel in platelet function |
Q38306728 | The P2X1 receptor and platelet function |
Q40618559 | Thrombopoietin Enhances Rapid Current Responses Mediated by P2X1 Receptors on Megakaryocytic Cells in Culture |
Search more.